Hims & Hers Health (HIMS)
(Delayed Data from NYSE)
$45.46 USD
+1.40 (3.18%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $46.30 +0.84 (1.85%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HIMS 45.46 +1.40(3.18%)
Will HIMS be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for HIMS based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for HIMS
Hims & Hers Scales AI-Driven Personalized Health and Wellness
Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings?
HIMS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Analysts Estimate Nyxoah SA (NYXH) to Report a Decline in Earnings: What to Look Out for
Hims & Hers Health, Inc. (HIMS) Stock Dips While Market Gains: Key Facts
HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now?
Other News for HIMS
200 Day Moving Average Resistance appears for HIMS after 3.18% move
Exploring Hims & Hers Health's Earnings Expectations
Hims & Hers Q3 Preview: Growth Faces a Confidence Test
Is HIMS gaining bearish strength? Fell Below 200 Day Moving Average shows up after tumbling 5.51%
Hims & Hers Health Q3 20a25 Earnings Preview